With more than one in 10 Americans facing an increased risk of stroke, heart attack and high blood pressure because of untreated sleep apnea, a new University of Maryland School of Medicine study ...

Posttraumatic stress disorder (PTSD) may enhance the risk for obstructive sleep apnea (OSA) in older male veterans, the results of a cross-sectional twin study suggested. However, additional ...

Please provide your email address to receive an email when new articles are posted on . Veterans with greater apnea-hypopnea index scores saw less improvement with esketamine for PTSD. This outcome ...

Obstructive sleep apnea (OSA) was associated with a significantly increased risk for adverse health outcomes and healthcare resource use among military personnel in the US, according to data from ...

Maybe you know you snore like a bear, but you don’t feel much urgency to look into it. Or maybe you have been told to wear a continuous positive airway pressure, or CPAP, machine for sleep apnea, but ...

HONOLULU (Reuters Health) - New research shows high rates of sleep disorders among veterans of America's wars in Iraq and Afghanistan who have post-traumatic stress disorder (PTSD) or head injuries.

Alcohol use disorder (AUD) and mental health disorders, such as post-traumatic stress disorder (PTSD), are common among veterans. Recent research suggests that AUD may increase the risk of sleep apnea ...

Obstructive sleep apnea is characterized by disordered breathing during sleep and is associated with major cardiovascular complications; excess adiposity is an etiologic risk factor. Tirzepatide may ...

Research suggests that CPAP may improve headaches in some people with sleep apnea. But some people may develop headaches if their CPAP mask is too tight, if they develop nasal congestion, or if CPAP ...

Share on Pinterest A clinical trial shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms in people with obesity. NurPhoto/Getty Images Around 70% of people who have obstructive ...

Following Novo Nordisk’s recent Wegovy approval to cut heart risks in adults with obesity, Eli Lilly appears to be homing in on the next potential label expansion for its rival GIP/GLP-1 weight-loss ...